通过腺苷对突触进行调谐和微调。
Tuning and fine-tuning of synapses with adenosine.
机构信息
Institute of Pharmacology and Neurosciences, Faculty of Medicine and Unit of Neurosciences, Institute of Molecular Medicine, University of Lisbon, Lisboa, Portugal.
出版信息
Curr Neuropharmacol. 2009 Sep;7(3):180-94. doi: 10.2174/157015909789152128.
The 'omnipresence' of adenosine in all nervous system cells (neurons and glia) together with the intensive release of adenosine following insults, makes adenosine as a sort of 'maestro' of synapses leading to the homeostatic coordination of brain function. Besides direct actions of adenosine on the neurosecretory mechanisms, where adenosine operates to tune neurotransmitter release, receptor-receptor interactions as well as interplays between adenosine receptors and transporters occur as part of the adenosine's attempt to fine tuning synaptic transmission. This review will focus on the different ways adenosine can use to trigger or brake the action of several neurotransmitters and neuromodulators. Adenosine receptors cross talk with other G protein coupled receptors (GPCRs), with ionotropic receptors and with receptor kinases. Most of these interactions occur through A2A receptors, which in spite their low density in some brain areas, such as the hippocampus, may function as metamodulators. Tonic adenosine A2A receptor activity is a required step to allow synaptic actions of neurotrophic factors, namely upon synaptic transmission at both pre- and post-synaptic level as well as upon synaptic plasticity and neuronal survival. The implications of these interactions in normal brain functioning and in neurologic and psychiatric dysfunction will be discussed.
腺苷在所有神经系统细胞(神经元和神经胶质细胞)中的“无处不在”,以及损伤后腺苷的大量释放,使腺苷成为一种“指挥家”,调节大脑功能的稳态协调。除了腺苷对神经分泌机制的直接作用,在神经递质释放的调节中,受体-受体相互作用以及腺苷受体和转运体之间的相互作用是腺苷微调突触传递的一部分。这篇综述将重点介绍腺苷可以用来触发或抑制几种神经递质和神经调质作用的不同方式。腺苷受体与其他 G 蛋白偶联受体(GPCR)、离子型受体和受体激酶相互作用。这些相互作用大多发生在 A2A 受体上,尽管它们在某些脑区(如海马体)的密度较低,但可能作为变构调节剂发挥作用。持续的腺苷 A2A 受体活性是允许神经营养因子发挥突触作用的必要步骤,即在突触前和突触后水平的突触传递以及突触可塑性和神经元存活中。将讨论这些相互作用在正常大脑功能以及神经和精神功能障碍中的意义。
相似文献
Curr Neuropharmacol. 2009-9
Acta Physiol (Oxf). 2010-3-24
Handb Exp Pharmacol. 2009
J Neurochem. 2016-12
Prog Neurobiol. 2002-12
Eur J Pharmacol. 1999-6-30
Neuropharmacology. 2023-9-15
引用本文的文献
Brain Behav Immun Health. 2022-10-28
Front Cell Neurosci. 2019-4-16
Anat Rec (Hoboken). 2018-10-12
Br J Pharmacol. 2018-10-17
本文引用的文献
Handb Exp Pharmacol. 2009
Neuropsychopharmacology. 2009-6
Proc Natl Acad Sci U S A. 2009-1-13
Biomaterials. 2008-9